Free Trial
NASDAQ:ABVX

ABIVAX Société Anonyme (ABVX) Stock Price, News & Analysis

ABIVAX Société Anonyme logo
$10.32
-0.17 (-1.62%)
(As of 10/31/2024 ET)

About ABIVAX Société Anonyme Stock (NASDAQ:ABVX)

Key Stats

Today's Range
$10.27
$10.50
50-Day Range
$8.97
$12.71
52-Week Range
$8.75
$17.02
Volume
10,449 shs
Average Volume
92,681 shs
Market Capitalization
$653.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$36.50
Consensus Rating
Moderate Buy

Company Overview

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.

ABIVAX Société Anonyme Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
67th Percentile Overall Score

ABVX MarketRank™: 

ABIVAX Société Anonyme scored higher than 67% of companies evaluated by MarketBeat, and ranked 396th out of 993 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    ABIVAX Société Anonyme has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 6 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    ABIVAX Société Anonyme has received no research coverage in the past 90 days.

  • Read more about ABIVAX Société Anonyme's stock forecast and price target.
  • Earnings Growth

    Earnings for ABIVAX Société Anonyme are expected to grow in the coming year, from ($2.98) to ($2.86) per share.

  • Price to Book Value per Share Ratio

    ABIVAX Société Anonyme has a P/B Ratio of 3.06. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.41% of the float of ABIVAX Société Anonyme has been sold short.
  • Short Interest Ratio / Days to Cover

    ABIVAX Société Anonyme has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ABIVAX Société Anonyme has recently decreased by 16.53%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    ABIVAX Société Anonyme does not currently pay a dividend.

  • Dividend Growth

    ABIVAX Société Anonyme does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.41% of the float of ABIVAX Société Anonyme has been sold short.
  • Short Interest Ratio / Days to Cover

    ABIVAX Société Anonyme has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ABIVAX Société Anonyme has recently decreased by 16.53%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    ABIVAX Société Anonyme has a news sentiment score of 1.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for ABIVAX Société Anonyme this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    1 people have added ABIVAX Société Anonyme to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, ABIVAX Société Anonyme insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    47.91% of the stock of ABIVAX Société Anonyme is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about ABIVAX Société Anonyme's insider trading history.
Receive ABVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ABIVAX Société Anonyme and its competitors with MarketBeat's FREE daily newsletter.

ABVX Stock News Headlines

ABIVAX Société Anonyme (NASDAQ:ABVX) Short Interest Update
Protect Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
ABIVAX Société Anonyme (0RA9.L)
See More Headlines

ABVX Stock Analysis - Frequently Asked Questions

ABIVAX Société Anonyme's stock was trading at $10.70 at the beginning of 2024. Since then, ABVX stock has decreased by 3.6% and is now trading at $10.32.
View the best growth stocks for 2024 here
.

ABIVAX Société Anonyme (ABVX) raised $217 million in an initial public offering on Friday, October 20th 2023. The company issued 18,699,460 shares at a price of $11.60 per share.

ABIVAX Société Anonyme's top institutional investors include abrdn plc (0.50%) and Rosalind Advisors Inc. (0.22%).

Shares of ABVX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that ABIVAX Société Anonyme investors own include Adverum Biotechnologies (ADVM), APi Group (APG), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Boot Barn (BOOT), G1 Therapeutics (GTHX) and Howard Hughes (HHH).

Company Calendar

Today
10/31/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ABVX
Previous Symbol
NASDAQ:ABVX
Fax
N/A
Employees
61
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$36.50
High Stock Price Target
$50.00
Low Stock Price Target
$16.00
Potential Upside/Downside
+252.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$3.37 per share

Miscellaneous

Free Float
N/A
Market Cap
$656.37 million
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

This page (NASDAQ:ABVX) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners